DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (162)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 162   Next >>

Possible Prednisone side effects in male

Reported by a physician from Brazil on 2012-08-21

Patient: male, weighing 53.1 kg (116.8 pounds)

Reactions: Pneumonia, Deep Vein Thrombosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-01
    End date: 2012-02-14

Abiraterone Acetate
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-01
    End date: 2012-02-14

Other drugs received by patient: Hydromorphone HCL



Possible Prednisone side effects in male

Reported by a physician from Romania on 2012-08-21

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Cardio-Respiratory Arrest, Anaemia, Dehydration

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-16
    End date: 2012-06-16

Abiraterone Acetate
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-16
    End date: 2012-06-16



Possible Prednisone side effects in 64 year old male

Reported by a physician from Poland on 2012-08-21

Patient: 64 year old male

Reactions: Disseminated Intravascular Coagulation

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Start date: 2012-07-04
    End date: 2012-07-04

Cabazitaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-14
    End date: 2012-06-14

Prednisone
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-14



Possible Prednisone side effects in male

Reported by a physician from Brazil on 2012-08-21

Patient: male, weighing 64.4 kg (141.7 pounds)

Reactions: Diarrhoea

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-11-10
    End date: 2012-06-23

Abiraterone Acetate
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-11-10
    End date: 2012-06-23

Other drugs received by patient: Goserelin



Possible Prednisone side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09

Patient: 60 year old female

Reactions: Myelofibrosis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Idiopathic Thrombocytopenic Purpura

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Bicnu
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 4 years, intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Prednisone
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-05-05

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-05-19

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-04-08

Vepesid
    Dosage: intravenous (not otherwise sepcified)
    Indication: Multiple Myeloma

Vincristine Sulfate
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen; Corticosteroids



Possible Prednisone side effects in 58 year old male

Reported by a physician from United States on 2012-08-08

Patient: 58 year old male, weighing 121.7 kg (267.7 pounds)

Reactions: Encephalopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2011-09-30
    End date: 2011-09-30

Docetaxel
    Start date: 2012-02-23
    End date: 2012-02-23

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-09-30
    End date: 2012-03-05

Other drugs received by patient: Glipizide; Lisinopril; Herbal Preparation; Dorzolamide; Rosuvastatin; Sertraline Hydrochloride; Aspirin; Bisoprolol Fumarate; Goserelin; Pioglitazone; Folic Acid; ST Mary's Thistle; Acyclovir; Ezetimibe; Metformin Hydrochloride; Fish OIL; Garlic; Biotin; Carboxymethylcellulose Sodium; Doxycycline Hyclate; Hydrocortisone; Calcium; Cholecalciferol



Possible Prednisone side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: 67 year old male

Reactions: Nasopharyngitis, Cataract, Bronchitis, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Nexium
    Administration route: Oral

Prednisone

Toprol-XL
    Administration route: Oral



Possible Prednisone side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-07

Patient:

Reactions: Lung Infection, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-05

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-12

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-12

Rituximab
    Dosage: 375 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Rituximab
    Dosage: 375 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Rituximab
    Dosage: 375 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Vorinostat
    Dosage: on day 1-9
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-07

Vorinostat
    Dosage: on day 1-9
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-06
    End date: 2012-02-14

Vorinostat
    Dosage: on day 1-5
    Administration route: Oral
    Start date: 2012-07-10
    End date: 2012-07-14



Possible Prednisone side effects in male

Reported by a physician from France on 2012-08-07

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Lymphoma
    Start date: 2012-07-05
    End date: 2012-07-05

Cyclophosphamide
    Indication: Lymphoma
    Start date: 2012-07-05
    End date: 2012-07-05

Istodax

Istodax
    Dosage: 21.6 milligram
    Indication: Lymphoma
    Start date: 2012-07-05
    End date: 2012-07-05

Oncovin
    Indication: Lymphoma
    Start date: 2012-07-05
    End date: 2012-07-05

Prednisone
    Indication: Lymphoma
    Start date: 2012-07-05
    End date: 2012-07-05



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-08-06

Patient: male, weighing 125.0 kg (275.0 pounds)

Reactions: Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-22
    End date: 2012-07-05

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-22
    End date: 2012-07-04

Other drugs received by patient: Aspirin; Nexium; Degarelix; Acetaminophen; Docusate; Boniva; Nasonex; Pepcid; Hydrocodone Bitartrate; Potassium Chloride; Metamucil-2; Vitamin D; Carafate; Nasonex; Bumetanide; Potassium Chloride; Pepcid; Carafate; Toviaz; Potassium Chloride; Milk OF Magnesia TAB; Potassium Chloride; Calcium with Vitamin D; Miralax



Possible Prednisone side effects in 49 year old female

Reported by a pharmacist from United States on 2012-08-06

Patient: 49 year old female, weighing 35.4 kg (77.9 pounds)

Reactions: Medication Error, Endocarditis, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: tapering dosage daily po
    Administration route: Oral
    Indication: Hepatic Failure
    Start date: 2012-06-20
    End date: 2012-07-07

Prednisone
    Dosage: tapering dosage daily po
    Administration route: Oral
    Indication: Hepatic Failure
    Start date: 2012-06-25
    End date: 2012-07-18

Other drugs received by patient: Furosemide; Spironolactone; Levothyroxine Sodium



Possible Prednisone side effects in 74 year old male

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: 74 year old male

Reactions: Blood Bilirubin Increased, Pneumonia, Atrial Fibrillation, Hepatic Enzyme Increased, Death, Enterococcal Sepsis, Fluid Retention, Cardiac Failure Congestive

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Daunorubicin HCL
    Dosage: on days 1,8,15,22
    Indication: Acute Lymphocytic Leukaemia

Elspar

Methotrexate
    Dosage: day15
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Indication: Acute Lymphocytic Leukaemia

Sprycel
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-22

Vincristine
    Dosage: on days 1,8,15,22
    Indication: Acute Lymphocytic Leukaemia



Possible Prednisone side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 56 year old female

Reactions: Abdominal Pain, Confusional State, Tachycardia, Mental Status Changes, Clostridium Difficile Colitis, Pneumocystis Jiroveci Pneumonia, Abdominal Distension, Respiratory Muscle Weakness, Hypoxia, Clostridial Infection, Hypotension, Urinary Tract Infection Enterococcal, Respiratory Failure, Diarrhoea, Pseudomembranous Colitis, Enteritis Infectious, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Levofloxacin
    Dosage: 250 mg
    Indication: Antibiotic Prophylaxis

Prednisone
    Dosage: 10 mg
    Indication: Chronic Graft Versus Host Disease

Sulfamethoxazole and Trimethoprim
    Dosage: double strength
    Administration route: Oral
    Indication: Antibiotic Prophylaxis

Sulfamethoxazole and Trimethoprim
    Indication: Pneumocystis Jiroveci Pneumonia

Other drugs received by patient: Pentamidine; Fluconazole; Acyclovir



Possible Prednisone side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Rhabdomyolysis, Dehydration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Prednisone
    Administration route: Oral

Zocor
    Administration route: Oral

Other drugs received by patient: Fluticasone Furoate; Systane Ultra; Restasis; Aspirin; Metoprolol Tartrate; Zaleplon



Possible Prednisone side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: female

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Bicnu
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2004-01-01
    End date: 2008-01-01

Dexamethasone
    Start date: 2008-04-08
    End date: 2008-09-01

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Prednisone
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Velcade
    Indication: Multiple Myeloma
    Start date: 2008-04-08
    End date: 2008-06-01

Vepesid
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Vincristine
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01



Possible Prednisone side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: female

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Bicnu
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Dexamethasone
    Start date: 2008-04-08

Dexamethasone
    Start date: 2008-06-01
    End date: 2008-01-01

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2008-05-05

Dexamethasone
    Start date: 2008-05-19

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Prednisone
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Velcade
    Indication: Multiple Myeloma
    Start date: 2008-04-08
    End date: 2008-09-01

Vepesid
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Vincristine
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01



Possible Prednisone side effects in

Reported by a physician from Korea, Republic of on 2012-07-30

Patient:

Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Doxil
    Dosage: 50 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Prednisone
    Dosage: 100 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-26

Velcade
    Dosage: 1.60 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Vincristine
    Dosage: 1.4 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22



Possible Prednisone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Prednisone side effects in male

Reported by a physician from Canada on 2012-07-30

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Platelet Count Decreased, Neutropenia, Altered State of Consciousness

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-04-16
    End date: 2012-04-23

Abiraterone Acetate
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-04-29

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-04-02

Other drugs received by patient: Phosphate



Possible Prednisone side effects in female

Reported by a physician from United Kingdom on 2012-07-27

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Anaemia, Neutropenia, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Furosemide

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-23



Possible Prednisone side effects in male

Reported by a physician from Mexico on 2012-07-27

Patient: male, weighing 2.0 kg (4.4 pounds)

Reactions: Klippel-Feil Syndrome, Respiratory Distress

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Foetal Exposure During Pregnancy

Prednisone
    Indication: Foetal Exposure During Pregnancy



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-27

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Meningitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-03-08
    End date: 2012-06-13

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-03-08
    End date: 2012-06-13

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-03-07
    End date: 2012-06-13

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-03-08
    End date: 2012-06-13



Possible Prednisone side effects in

Reported by a physician from Korea, Republic of on 2012-07-24

Patient:

Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Doxil
    Dosage: 50 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Prednisone
    Dosage: 100 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-26

Velcade
    Dosage: 1.60 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Vincristine
    Dosage: 1.4 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22



Possible Prednisone side effects in female

Reported by a physician from Switzerland on 2012-07-19

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Alveolitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actemra
    Indication: Temporal Arteritis
    Start date: 2012-06-01
    End date: 2012-06-01

Methotrexate
    Administration route: Oral

Methotrexate
    Indication: Temporal Arteritis
    Start date: 2012-01-03
    End date: 2012-05-29

Methotrexate

Prednisone

Prednisone
    Administration route: Oral
    Indication: Temporal Arteritis
    Start date: 2011-09-01

Prednisone



Possible Prednisone side effects in

Reported by a physician from Korea, Republic of on 2012-07-18

Patient:

Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750.00 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Doxorubicin HCL
    Dosage: 50.00 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Prednisone
    Dosage: 100.00 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-26

Velcade
    Dosage: 1.60 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22

Vincristine
    Dosage: 1.40 mg/m2, unk
    Indication: T-Cell Lymphoma
    Start date: 2008-01-24
    End date: 2008-02-22



Possible Prednisone side effects in

Reported by a physician from United Kingdom on 2012-07-18

Patient:

Reactions: Neutropenic Sepsis, Respiratory Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1300 mg, unk
    Start date: 2010-11-05

Cyclophosphamide
    Dosage: 1300 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2010-08-24
    End date: 2010-11-05

Doxorubicin HCL
    Dosage: 90 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2010-08-24

Doxorubicin HCL
    Dosage: 83 unk, unk
    Start date: 2010-11-05

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2010-08-24
    End date: 2010-11-05

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2010-11-05

Velcade
    Dosage: 2.8 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2010-08-24

Velcade
    Dosage: 1.3 unk, unk
    Start date: 2010-11-05
    End date: 2010-11-12

Vincristine
    Dosage: 2 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2010-08-24

Other drugs received by patient: Metoclopramide; Simvastatin; Ramipril; Acyclovir; Piperacillin and Tazobactam; Fluoxetine HCL; E45; Aspirin; Gaviscon; Bisoprolol Fumarate; Omeprazole



Possible Prednisone side effects in 56 year old female

Reported by a physician from United States on 2012-07-18

Patient: 56 year old female, weighing 81.0 kg (178.2 pounds)

Reactions: Fluid Overload, Gastroenteritis Viral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Humira
    Start date: 2012-02-29

Humira
    Indication: Uveitis
    Start date: 2011-09-14
    End date: 2012-02-08

Prednisone
    Dosage: 60 mg
    Administration route: Oral
    Indication: Uveitis
    Start date: 2011-09-14
    End date: 2011-09-27

Prednisone
    Dosage: 30 mg
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-18

Prednisone
    Dosage: 12.5 mg
    Administration route: Oral
    Start date: 2011-11-02
    End date: 2011-11-08

Prednisone
    Dosage: 5 mg
    Administration route: Oral
    Start date: 2011-11-24
    End date: 2011-11-30

Prednisone
    Dosage: 7.5 mg
    Administration route: Oral
    Start date: 2011-11-17
    End date: 2011-11-23

Prednisone
    Dosage: 10 mg
    Administration route: Oral
    Start date: 2011-11-09
    End date: 2011-11-16

Prednisone
    Dosage: 15 nr
    Administration route: Oral
    Start date: 2011-10-26
    End date: 2011-11-01

Prednisone
    Dosage: 3 mg
    Administration route: Oral
    Start date: 2011-12-08
    End date: 2011-12-14

Prednisone
    Dosage: 1 mg
    Administration route: Oral
    Start date: 2011-12-22
    End date: 2011-12-28

Prednisone
    Dosage: 50 mg
    Administration route: Oral
    Start date: 2011-09-28
    End date: 2011-10-04

Prednisone
    Dosage: 40 mg
    Administration route: Oral
    Start date: 2011-10-05
    End date: 2011-10-11

Prednisone
    Dosage: 20 mg
    Administration route: Oral
    Start date: 2011-10-19
    End date: 2011-10-25

Prednisone
    Dosage: 2 mg
    Administration route: Oral
    Start date: 2011-12-15
    End date: 2011-12-21

Prednisone
    Dosage: 4 mg
    Administration route: Oral
    Start date: 2011-12-01
    End date: 2011-12-07

Other drugs received by patient: Lisinopril; Lorazepam; Ketorolac Tromethamine; Mycophenolate Mofetil; Promethazine; Rosuvastatin; Folic Acid; Tramadol HCL; Metoprolol Succinate; Diclofenac Sodium; Furosemide; Sertraline Hydrochloride; Amlodipine Maleate; Mycophenolate Mofetil; Gabapentin; Vicodin; Cyclobenzaprine HCL; Loratadine; Furosemide; Mycophenolate Mofetil; Calcium with D; Pantoprazole Sodium Sesquihydrate; Amlodipine Maleate; Bupropion Hydrochloride; Suprax; Estradiol



Possible Prednisone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Prednisone side effects in 70 year old male

Reported by a physician from Canada on 2012-07-17

Patient: 70 year old male

Reactions: Small Intestinal Obstruction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-05
    End date: 2012-06-05

Cabazitaxel
    Start date: 2012-06-26
    End date: 2012-06-26

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-05
    End date: 2012-06-05

Other drugs received by patient: Ezetimibe; Simvastatin; Bisoprolol Fumarate; Aspirin



Possible Prednisone side effects in male

Reported by a physician from Italy on 2012-07-17

Patient: male, weighing 53.0 kg (116.6 pounds)

Reactions: Subdural Haemorrhage

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-07
    End date: 2012-06-17

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-06-07
    End date: 2012-06-17

Other drugs received by patient: Leuprolide Acetate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017